Renata Ferrarotto Selected Research

Renata Ferrarotto Research Topics

Disease

77	Neoplasms (Cancer) 04/2024 - 07/2010
18	Carcinoma (Carcinomatosis) 03/2024 - 12/2014
18	Squamous Cell Carcinoma of Head and Neck 01/2023 - 01/2014
16	Head and Neck Neoplasms (Head and Neck Cancer) 12/2023 - 09/2018
16	Oropharyngeal Neoplasms 01/2021 - 09/2015
15	Neoplasm Metastasis (Metastasis) 04/2024 - 09/2011
11	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2024 - 12/2017
10	Adenoid Cystic Carcinoma (Cylindroma) 03/2024 - 01/2017
9	Anaplastic Thyroid Carcinoma 01/2023 - 01/2016
6	Deglutition Disorders (Dysphagia) 01/2021 - 01/2018
5	Disease Progression 01/2023 - 12/2017
4	Carcinogenesis 01/2021 - 09/2015
4	Xerostomia 01/2021 - 01/2020
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 04/2016
3	Colorectal Neoplasms (Colorectal Cancer) 03/2013 - 09/2011
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 01/2021
2	Osteoradionecrosis 01/2021 - 01/2021
2	Hypesthesia (Numbness) 01/2021 - 01/2020
2	Sinonasal undifferentiated carcinoma 12/2020 - 01/2019
2	Acinar Cell Carcinoma 08/2020 - 06/2020
2	Basal Cell Carcinoma (Rodent Ulcer) 07/2019 - 01/2019
1	Hypophysitis 11/2023
1	Cardiomyopathies (Cardiomyopathy) 11/2023
1	Inflammation (Inflammations) 07/2023
1	Nerve Degeneration 07/2023
1	Papillomavirus Infections 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Lung Neoplasms (Lung Cancer) 08/2022
1	Critical Illness (Critically Ill) 08/2022
1	Lymphadenopathy 01/2022
1	Spontaneous Remission 01/2022
1	Adenocarcinoma 01/2022

Drug/Important Bio-Agent (IBA)

11	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2019
11	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2015
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2010
5	pembrolizumabIBA 04/2024 - 11/2018
5	PlatinumIBA 12/2021 - 01/2018
4	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 12/2014
4	Phosphotransferases (Kinase)IBA 01/2022 - 11/2018
4	Cetuximab (Erbitux)FDA Link 12/2021 - 01/2018
3	LigandsIBA 04/2024 - 12/2014
3	cemiplimabIBA 11/2023 - 10/2022
3	RNA (Ribonucleic Acid)IBA 01/2023 - 08/2020
3	NivolumabIBA 01/2023 - 01/2019
3	AntibodiesIBA 01/2023 - 01/2019
3	Fluorouracil (Carac)FDA LinkGeneric 12/2021 - 09/2011
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2021
3	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 01/2021
3	Protons (Proton)IBA 01/2021 - 12/2020
3	CytokinesIBA 10/2020 - 07/2010
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 04/2012
2	human ERBB2 proteinIBA 01/2023 - 01/2018
2	Keratins (Keratin)IBA 01/2023 - 01/2022
2	AndrogensIBA 01/2023 - 12/2014
2	tyrosine receptor (receptor, tyrosine)IBA 01/2022 - 01/2021
2	Peptides (Polypeptides)IBA 01/2022 - 01/2019
2	VaccinesIBA 01/2022 - 01/2019
2	trilaciclibIBA 01/2021 - 01/2021
2	Cell-Free Nucleic AcidsIBA 01/2021 - 12/2018
2	HhAntag691IBA 07/2019 - 01/2019
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019 - 01/2018
2	dabrafenibIBA 01/2019 - 01/2018
2	trametinibIBA 01/2019 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 12/2018 - 12/2014
2	Bevacizumab (Avastin)FDA Link 01/2018 - 03/2013
2	ErbB Receptors (EGF Receptor)IBA 12/2017 - 01/2014
1	thiamine triphosphorate (TTP)IBA 03/2024
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 12/2023
1	PotassiumIBA 11/2023
1	Interferon Type IIBA 07/2023
1	Interleukin-6 (Interleukin 6)IBA 07/2023
1	Axitinib (AG 013736)IBA 01/2023
1	MetalsIBA 01/2023
1	Trastuzumab (Herceptin)FDA Link 01/2023
1	avelumabIBA 01/2023
1	Chromogranin AIBA 01/2023
1	Immunoconjugates (Immunoconjugate)IBA 01/2023
1	IpilimumabIBA 01/2023
1	SynaptophysinIBA 01/2023
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2022
1	Investigational DrugsIBA 01/2022
1	liquid crystal polymerIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022

Therapy/Procedure

46	Therapeutics 03/2024 - 09/2011
31	Radiotherapy 11/2023 - 01/2017
15	Drug Therapy (Chemotherapy) 01/2022 - 09/2011
12	Immunotherapy 04/2024 - 01/2019
10	Proton Therapy 01/2023 - 01/2020
7	Neoadjuvant Therapy 03/2024 - 10/2020
7	Induction Chemotherapy 01/2021 - 01/2017
5	Re-Irradiation 11/2021 - 01/2020
4	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2023 - 01/2018
4	Aftercare (After-Treatment) 01/2021 - 11/2019
3	Neck Dissection (Radical Neck Dissection) 01/2023 - 11/2019
2	Gastrostomy 01/2021 - 01/2018
1	Lymph Node Excision (Lymph Node Dissection) 03/2024
1	Adjuvant Radiotherapy 11/2023
1	Surgical Amputation (Amputations) 11/2023